The efficacy of 0.05% cyclosporin eye drop for dry eye disease
Not Applicable
Completed
- Conditions
- Diseases of the eye and adnexa
- Registration Number
- KCT0006923
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Age over 19 years of age with dry eye syndorome with meibomian gland dysfunction. The subjects were those who voluntarily agreed to participate in this study through the clinical trial recruitment notice of our hospital.
Exclusion Criteria
Patients with ocular surface disease, previous ocular surgery, glaucoma, contact lens use, and systemic immune-related disease, receiving cyclosporine treatment for more than a year, and pregnant and lactating women were excluded from the study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method id margin telangiectasia, Meibomian gland secretion, Conjunctival injection, Corneal staining, Tear break-up time, Lipid layer thickness
- Secondary Outcome Measures
Name Time Method Ocular Surface Disease Index questionnaire (ocular irritation, ocular pain, glare, decreased visual acuity)